VistaGen Therapeutics Inc Stock Analysis
Technical stock analysis for 22 January 2019
VistaGen Therapeutics Inc fell by -6.55% in the last day from $1.68 to $1.57 The price has been going up and down for this period, and there has been a -5.99% loss for the last 2 weeks. Volume has increased in the last day by 2 243 shares, but on falling prices. This may be an early warning and the risk will be increased slightly for the next couple of days. In total, 102 269 shares bought and sold for approximately $160 562.00.
Close price at the end of the last trading day (Tuesday, 22nd Jan 2019) of the VTGN stock was $1.57. This is 6.55% less than the trading day before Friday, 18th Jan 2019.
During day the stock fluctuated 7.01% from a day low at $1.57 to a day high of $1.68.
30 day high of the VTGN stock price was $1.85 and low was $1.26.
90 day high was $2.29 and low was $1.26.
52 week high for the VistaGen Therapeutics Inc - $2.44 and low - $0.81.
VistaGen Therapeutics Inc lies in the middle of a very wide and falling trend in the short term and further fall within the trend is signaled. Given the current short-term trend, the stock is expected to fall -25.05% during the next 3 months and, with 90% probability hold a price between $0.83 and $1.28 at the end of this period.
There are few to none technical positive signals at the moment. VistaGen Therapeutics Inc holds sales signals from both short- and long-term moving averages. On corrections up there will be some resistance from the lines at $1.68 and $1.62. A break-up above any of these levels will issue buy signals. A sales signal was issued from a pivot top point on Friday January 11, 2019, which indicates further falls until a new bottom pivot has been found. VistaGen Therapeutics Inc gained volume on the last day, but on falling prices. In technical terms this is called divergence and may be an early warning. In some cases, increasing volume on falling prices may be considered positive, but that is mainly in typical "sell-off's".
Relative Strength Index (RSI)
RSI14 is 56 and the stock is currently not being overbought or oversold
Support & Resistance
On the downside, the stock finds support just below today's level from accumulated volume at $1.48 and $1.45.
There is natural risk involved when a stock is testing a support level, since if this is broken, the stock then may fall to the next support level. In this case, VistaGen Therapeutics Inc finds support just below today's level at $1.48. If this is broken, then the next support from accumulated volume will be at $1.45 and $1.28.
This stock may move much during a day (volatility) and with a large prediction interval from the Bollinger Band this stock is considered to be "high risk". During the last day, the stock moved $0.11 between high and low, or 7.01%. For the last week, the stock has had a daily average volatility of 5.11%.
Our recommended stoploss: We hold a sell evaluation for this stock. No stop-loss set.
Very Low Low Medium High Very High
VistaGen Therapeutics Inc holds several negative signals and is within a very wide and falling trend, so we believe it will still perform weakly in the next couple of days or weeks. We therefore hold a negative evaluation of this stock. Due to some small weaknesses in the technical picture we have downgraded our recommendation for this stock since last evaluation from a Buy Candidate to a Sell Candidate.
|VTGN $1.57 $-0.11(-6.55%)|
VTGN is down $0.11 today, but where's it headed in 2019?
|Zacks Investment Research is releasing its prediction for VTGN based on the 1-3 month system that more than doubles the S&P 500.
Click here – the VTGN analysis is free »